Human Pedigree Analysis
人类谱系分析
基本信息
- 批准号:7695944
- 负责人:
- 金额:$ 10.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-28 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AppointmentBreastBusinessesCancer CenterCancer Center Support GrantClientClinicClinicalClinical DataClinical TrialsCollectionColorectal CancerCommunicationCommunication MethodsCommunitiesComplexComputer softwareDataData CollectionData SourcesDatabasesDevelopmentDiseaseDivision of Cancer PreventionElectronicsEnvironmentExtended FamilyFamilyFamily StudyFamily history ofFamily memberFocus GroupsFundingGeneticGenetic CounselingGenetic DatabasesGenetic Predisposition to DiseaseGenetic ResearchGenetic screening methodGenotypeHealthHousingHumanInformaticsInformation ServicesInformation SystemsInheritedInternetLaboratoriesLinkMaintenanceMalignant NeoplasmsMedicalMedical RecordsMethodsMutationOnline SystemsOvarianPatientsPediatricsPeer ReviewPhase III Clinical TrialsPhysiciansPopulation StudyPredispositionPreventionProbabilityProcessProductionProfessional counselorProtocols documentationQuestionnairesRecordsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesRiskRisk AssessmentRisk FactorsScheduleScreening procedureSecureSecurityServicesSiteSpecimenStandards of Weights and MeasuresStructureSystemTimeUpdateVisualWorkadvanced systembasecancer geneticscancer riskcancer sitecomputer programcomputerized data processingdata managementdatabase designdesiredigitalfirewallgenetic analysisgenetic linkage analysisgenetic pedigreegenome wide association studyimprovedmigrationprogramssample collectionsystems researchtooltraitweb interface
项目摘要
Genetic information has helped researchers and physicians to identify major risk factors for disease and to
manage health risks more effectively through improved prevention, screening and family history. The Human
Pedigree Analysis Resource (HPAR) designs database tools and methods for the collection and analysis of
pedigree data. The HPAR staff consists of the facility director, two Co-Directors, an Informatics Manager,
four programmer analysts, a system analyst II and a graduate research assistant. The HPAR database
currently supports the Human Clinical Cancer Genetics clinics for breast, ovarian, and colorectal cancers,
and provides support to researchers investigating the genetic basis of several other cancer sites. The HPAR
has been successful in providing data management support for the collection and analysis of family history
information for pedigree data collection, clinical and laboratory tracking information, and laboratory results.
During the past 5 years, the HPAR has had 15 users representing 13 CCSG programs, of which 88% are
peer-review funded. Long-term objectives are 1) to develop a more advanced genetics database system to
extend the HPAR's comprehensive electronic family history information system. This advanced system will
include a Web application that allows patients to complete an extended family-history questionnaire prior to
their appointment with a genetic counselor. Capturing data before a patient contact will allow genetic
counselors to perform automated genetic counseling assessments of the patient's risk for cancer
development and the probability of carrying a cancer-susceptibility mutation. 2) To convert the existing SQL
server from a two-tier SQL server-based client-server structure to a three-tier structure to make services
easily available to other clinicians who need pedigrees drawn from family history information. 3) To develop
an in-house interactive computer program for drawing family pedigrees and linking family data gathered for
genetics research. This program will be a valuable visual tool for geneticists in identifying clusters of
inherited traits and genotypes. Short-term objectives are 1) to avoid duplication of patient data by making
informatics tools easily-accessible and to use them to integrate information from different resources (CRIS,
CARE, and Clinic Station); 2) to provide analytical support for the application of complex genetic software to
identify inherited susceptibility to cancers including application of risk assessment software, linkage analysis
and genome-wide association analysis studies.
遗传信息帮助研究人员和医生确定疾病的主要危险因素,
通过改进预防、筛查和家族史,更有效地管理健康风险。人类
系谱分析资源(HPAR)设计了数据库工具和方法,用于收集和分析
谱系数据。HPAR工作人员包括设施主管、两名联合主管、一名信息学经理,
四名程序员分析员、一名二级系统分析员和一名研究生助理。HPAR数据库
目前支持乳腺癌、卵巢癌和结肠直肠癌的人类临床癌症遗传学诊所,
并为研究其他几个癌症部位的遗传基础的研究人员提供支持。HPAR
成功地为家族史的收集和分析提供了数据管理支持
用于谱系数据收集的信息、临床和实验室跟踪信息以及实验室结果。
在过去5年中,HPAR有15个用户,代表13个CCSG项目,其中88%是
同行评审资助。长期目标是:1)开发更先进的遗传学数据库系统,
扩展HPAR的综合电子家族史信息系统。这一先进的系统将
包括一个Web应用程序,允许患者在接受治疗前完成一份扩展的家族史问卷,
和遗传咨询师的预约在患者接触之前获取数据将允许遗传
咨询师对患者的癌症风险进行自动遗传咨询评估
发展和携带癌症易感性突变的可能性。2)转换现有SQL
服务器从基于SQL Server的两层客户端-服务器结构转变为三层服务器结构
容易提供给其他需要从家族史信息中提取谱系的临床医生。3)发展
一个内部的交互式计算机程序,用于绘制家庭谱系,并将收集的家庭数据连接起来,
遗传学研究这个程序将是遗传学家在识别集群的一个有价值的可视化工具,
遗传性状和基因型。短期目标是:1)通过以下方式避免重复患者数据:
信息学工具,并利用这些工具整合来自不同资源的信息(CRIS,
CARE和Clinic Station); 2)为复杂遗传软件的应用提供分析支持,
确定遗传性癌症易感性,包括风险评估软件的应用,连锁分析
和全基因组关联分析研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher I. Amos其他文献
Shared susceptibility variations in autoimmune diseases: a brief perspective on common issues
自身免疫性疾病的共同易感性变异:对常见问题的简要看法
- DOI:
10.1038/gene.2008.92 - 发表时间:
2009 - 期刊:
- 影响因子:5
- 作者:
M. Seldin;Christopher I. Amos - 通讯作者:
Christopher I. Amos
Hereditary medullary thyroid carcinoma: genetic annalysis of three related syndromes. Groupe d'Etude des Tumeurs a Calcitonine.
遗传性甲状腺髓样癌:三种相关综合征的遗传分析。
- DOI:
- 发表时间:
1989 - 期刊:
- 影响因子:0
- 作者:
Hagay Sobol;S. A. Narod;I. Schuffenecker;Christopher I. Amos;Ezekowitz Ra;Lenoir Gm - 通讯作者:
Lenoir Gm
Estimating the power of linkage analysis in hereditary breast cancer.
估计连锁分析在遗传性乳腺癌中的功效。
- DOI:
- 发表时间:
1990 - 期刊:
- 影响因子:9.8
- 作者:
S. A. Narod;Christopher I. Amos - 通讯作者:
Christopher I. Amos
Multi-ancestry GWAS meta-analyses of lung cancer reveal susceptibility loci and elucidate smoking-independent genetic risk
肺癌的多祖先全基因组关联研究荟萃分析揭示了易感位点并阐明了与吸烟无关的遗传风险
- DOI:
10.1038/s41467-024-52129-4 - 发表时间:
2024-10-04 - 期刊:
- 影响因子:15.700
- 作者:
Bryan R. Gorman;Sun-Gou Ji;Michael Francis;Anoop K. Sendamarai;Yunling Shi;Poornima Devineni;Uma Saxena;Elizabeth Partan;Andrea K. DeVito;Jinyoung Byun;Younghun Han;Xiangjun Xiao;Don D. Sin;Wim Timens;Jennifer Moser;Sumitra Muralidhar;Rachel Ramoni;Rayjean J. Hung;James D. McKay;Yohan Bossé;Ryan Sun;Christopher I. Amos;Saiju Pyarajan - 通讯作者:
Saiju Pyarajan
Uncovering shared genetic features between inflammatory bowel disease and systemic lupus erythematosus
- DOI:
10.1038/s41598-025-98991-0 - 发表时间:
2025-05-01 - 期刊:
- 影响因子:3.900
- 作者:
Vikram R. Shaw;Jinyoung Byun;Catherine Zhu;Rowland W. Pettit;Jeffrey M. Cohen;Younghun Han;Christopher I. Amos - 通讯作者:
Christopher I. Amos
Christopher I. Amos的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher I. Amos', 18)}}的其他基金
International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study
国际胆道癌遗传学联盟胆管癌全基因组关联研究
- 批准号:
10608848 - 财政年份:2023
- 资助金额:
$ 10.24万 - 项目类别:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
优化结直肠癌预防:利用风险预测和建模对锯齿状息肉进行多学科、基于人群的调查
- 批准号:
10436886 - 财政年份:2020
- 资助金额:
$ 10.24万 - 项目类别:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
优化结直肠癌预防:利用风险预测和建模对锯齿状息肉进行多学科、基于人群的调查
- 批准号:
9916850 - 财政年份:2020
- 资助金额:
$ 10.24万 - 项目类别:
Optimizing colorectal cancer prevention: a multi-disciplinary, population-based investigation of serrated polyps using risk prediction and modeling
优化结直肠癌预防:利用风险预测和建模对锯齿状息肉进行多学科、基于人群的调查
- 批准号:
10650289 - 财政年份:2020
- 资助金额:
$ 10.24万 - 项目类别:
相似海外基金
Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
- 批准号:
EP/Y03693X/1 - 财政年份:2024
- 资助金额:
$ 10.24万 - 项目类别:
Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
- 批准号:
EP/Y001613/1 - 财政年份:2024
- 资助金额:
$ 10.24万 - 项目类别:
Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
- 批准号:
10110204 - 财政年份:2024
- 资助金额:
$ 10.24万 - 项目类别:
Launchpad
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
- 批准号:
24K11748 - 财政年份:2024
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
- 批准号:
MR/X018199/1 - 财政年份:2024
- 资助金额:
$ 10.24万 - 项目类别:
Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
- 批准号:
EP/Y014995/1 - 财政年份:2024
- 资助金额:
$ 10.24万 - 项目类别:
Research Grant
Development of comprehensive PET imaging for precise diagnosis of breast cancer
开发用于乳腺癌精确诊断的综合PET成像
- 批准号:
23H02856 - 财政年份:2023
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of internal radiation therapy agents for refractory breast cancer based on phase-shift using focused ultrasound
基于聚焦超声相移的难治性乳腺癌体内放射治疗剂的开发
- 批准号:
23H02866 - 财政年份:2023
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The early detection of breast cancer using field cacerization.
使用现场癌症化早期检测乳腺癌。
- 批准号:
23K08094 - 财政年份:2023
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
- 批准号:
23K06748 - 财政年份:2023
- 资助金额:
$ 10.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




